Protease-activated receptors in hemostasis, thrombosis and vascular biology

被引:801
作者
Coughlin, SR
机构
[1] Univ Calif San Francisco, Dept Med, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
关键词
D O I
10.1111/j.1538-7836.2005.01377.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coagulation cascade and protease-activated receptors (PARs) together provide an elegant mechanism that links mechanical information in the form of tissue injury to cellular responses. These receptors appear to largely account for the cellular effects of thrombin and can mediate signaling to other trypsin-like proteases. An important role for PARs in hemostasis and thrombosis is established in animal models, and studies in knockout mice and nonhuman primates raise the question of whether PAR inhibition might offer an appealing new approach to the prevention and treatment of thrombosis. PARs may also trigger inflammatory responses to tissue injury. For example, PAR activation on endothelial cells and perhaps sensory afferents can trigger local accumulation of leukocytes and platelets and transudation of plasma. However, panoply of signaling systems and cell types orchestrates inflammatory responses, and efforts to define the relative importance and roles of PARs in various inflammatory processes are just beginning. Lastly, roles for PARs in blood vessel formation and other processes during embryonic development are emerging, and whether these reflect new roles for the coagulation cascade and/or PAR signaling to other proteases remains to be explored.
引用
收藏
页码:1800 / 1814
页数:15
相关论文
共 181 条
  • [91] Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets
    Klages, B
    Brandt, U
    Simon, MI
    Schultz, G
    Offermanns, S
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 144 (04) : 745 - 754
  • [92] p115 RhoGEF, a GTPase activating protein for Gα12 and Gα13
    Kozasa, T
    Jiang, XJ
    Hart, MJ
    Sternweis, PM
    Singer, WD
    Gilman, AG
    Bollag, G
    Sternweis, PC
    [J]. SCIENCE, 1998, 280 (5372) : 2109 - 2111
  • [93] Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes
    Kranzhofer, R
    Clinton, SK
    Ishii, K
    Coughlin, SR
    Fenton, JW
    Libby, P
    [J]. CIRCULATION RESEARCH, 1996, 79 (02) : 286 - 294
  • [94] RECEPTOR MECHANISM OF THROMBIN-INDUCED ENDOTHELIUM-DEPENDENT AND ENDOTHELIUM-INDEPENDENT CORONARY VASCULAR EFFECTS IN DOGS
    KU, DD
    ZALESKI, JK
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (04) : 609 - 616
  • [95] Platelet purinergic receptors
    Kunapuli, SP
    Dorsam, RT
    Kim, S
    Quinton, TM
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (02) : 175 - 180
  • [96] Signalling through phosphoinositide 3-kinases: the lipids take centre stage
    Leevers, SJ
    Vanhaesebroeck, B
    Waterfield, MD
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 219 - 225
  • [97] Lefkowitz R J, 1998, Adv Pharmacol, V42, P416
  • [98] Agonist recognition by proteinase-activated receptor 2 and thrombin receptor - Importance of extracellular loop interactions for receptor function
    Lerner, DJ
    Chen, M
    Tram, T
    Coughlin, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 13943 - 13947
  • [99] Delayed onset of inflammation in protease-activated receptor-2-deficient mice
    Lindner, JR
    Kahn, ML
    Coughlin, SR
    Sambrano, GR
    Schauble, E
    Bernstein, D
    Foy, D
    Hafezi-Moghadam, A
    Ley, K
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (11) : 6504 - 6510
  • [100] LIU LW, 1991, J BIOL CHEM, V266, P16977